| MYC regulates the antitumor immune response through CD47 and PD-L1 SC Casey, L Tong, Y Li, R Do, S Walz, KN Fitzgerald, AM Gouw, V Baylot, ... Science 352 (6282), 227-231, 2016 | 1481 | 2016 |
| Reversible tumorigenesis by MYC in hematopoietic lineages DW Felsher, JM Bishop Molecular cell 4 (2), 199-207, 1999 | 1174 | 1999 |
| c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma AP Weng, JM Millholland, Y Yashiro-Ohtani, ML Arcangeli, A Lau, C Wai, ... Genes & development 20 (15), 2096-2109, 2006 | 1133 | 2006 |
| MYC as a regulator of ribosome biogenesis and protein synthesis J Van Riggelen, A Yetil, DW Felsher Nature Reviews Cancer 10 (4), 301-309, 2010 | 1126 | 2010 |
| MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer CM Shachaf, AM Kopelman, C Arvanitis, Å Karlsson, S Beer, S Mandl, ... Nature 431 (7012), 1112-1117, 2004 | 1073 | 2004 |
| MYC activation is a hallmark of cancer initiation and maintenance M Gabay, Y Li, DW Felsher Cold Spring Harbor perspectives in medicine 4 (6), a014241, 2014 | 1060 | 2014 |
| The MYC oncogene — the grand orchestrator of cancer growth and immune evasion R Dhanasekaran, A Deutzmann, WD Mahauad-Fernandez, AS Hansen, ... Nature reviews Clinical oncology 19 (1), 23-36, 2022 | 945 | 2022 |
| Sustained loss of a neoplastic phenotype by brief inactivation of MYC M Jain, C Arvanitis, K Chu, W Dewey, E Leonhardt, M Trinh, CD Sundberg, ... Science 297 (5578), 102-104, 2002 | 894 | 2002 |
| NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis C Ma, AH Kesarwala, T Eggert, J Medina-Echeverz, DE Kleiner, P Jin, ... Nature 531 (7593), 253-257, 2016 | 792 | 2016 |
| Supramolecular stacking of doxorubicin on carbon nanotubes for in vivo cancer therapy Z Liu, AC Fan, K Rakhra, S Sherlock, A Goodwin, X Chen, Q Yang, ... Angewandte Chemie International Edition 48 (41), 7668-7672, 2009 | 647 | 2009 |
| HIF-dependent antitumorigenic effect of antioxidants in vivo P Gao, H Zhang, R Dinavahi, F Li, Y Xiang, V Raman, ZM Bhujwalla, ... Cancer cell 12 (3), 230-238, 2007 | 647 | 2007 |
| Cancer revoked: oncogenes as therapeutic targets DW Felsher Nature Reviews Cancer 3 (5), 375-379, 2003 | 619 | 2003 |
| Transient excess of MYC activity can elicit genomic instability and tumorigenesis DW Felsher, JM Bishop Proceedings of the National Academy of Sciences 96 (7), 3940-3944, 1999 | 564 | 1999 |
| Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation CH Wu, J Van Riggelen, A Yetil, AC Fan, P Bachireddy, DW Felsher Proceedings of the National Academy of Sciences 104 (32), 13028-13033, 2007 | 518 | 2007 |
| Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis Y Xiang, ZE Stine, J Xia, Y Lu, RS O’Connor, BJ Altman, AL Hsieh, ... The Journal of clinical investigation 125 (6), 2293-2306, 2015 | 504 | 2015 |
| Bioorthogonal cyclization-mediated in situ self-assembly of small-molecule probes for imaging caspase activity in vivo D Ye, AJ Shuhendler, L Cui, L Tong, SS Tee, G Tikhomirov, DW Felsher, ... Nature chemistry 6 (6), 519-526, 2014 | 465 | 2014 |
| Cancer prevention and therapy through the modulation of the tumor microenvironment SC Casey, A Amedei, K Aquilano, AS Azmi, F Benencia, D Bhakta, ... Seminars in cancer biology 35, S199-S223, 2015 | 446 | 2015 |
| CD4+ T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation K Rakhra, P Bachireddy, T Zabuawala, R Zeiser, L Xu, A Kopelman, ... Cancer cell 18 (5), 485-498, 2010 | 420 | 2010 |
| Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead WH Goodson III, L Lowe, DO Carpenter, M Gilbertson, A Manaf Ali, ... Carcinogenesis 36 (Suppl_1), S254-S296, 2015 | 392 | 2015 |
| The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma H Miess, B Dankworth, AM Gouw, M Rosenfeldt, W Schmitz, M Jiang, ... Oncogene 37 (40), 5435-5450, 2018 | 375 | 2018 |
